Icon

Contrave - (90MG;8MG: Tablet, Extended Release)

BUPROPION HYDROCHLORIDE; NALTREXONE HYDROCHLORIDE Takeda
90MG;8MG: Tablet, Extended Release
Less Than $1000 mn
Less Than 5
Less Than 5
More Than 5
Less Than 5
None None
CONTRAVE is indicated as an adjunct to a reduced-calorie diet and increased physical activity for chronic weight management in obese or over weight adults.
Yes
******* ** *** ***, ***** ** ***** **** ** **** ******* '*** (***** **, ****), '*** (**** **, ****), '*** (*** *, ****), '*** (*** *, ****), '*** (*** *, ****), '*** (**** **, ****), '***. (*** *, ****) *** *** ************ *********. ** ****** **** **** ******* ******* ** *** ****. ************, *** ******* ******* ***** ******* ******* *** ***** **** ******* ********* * ** *** ********* *******.
Contrave Patent 1 Patent 2 Patent 3 Patent 4 Patent 5 Patent 6 Patent 7 Patent 8 Patent 9 Patent 10 Patent 11 Patent 12
******* *** ** ** *** ** ** **** ** *** *, **** **** ** *** *, **** **** ** *** *, **** **** ** *** *, **** **** ** ** *** ********* **** ** *** **, **** *** ********* *** ********* *** *********
Company FTF Status / 180 days exclusivity 30-Months stay Current Litigation Status Current Approval Status Likelihood of launch
******* *** \ ** *** *, **** *** ** ** ** ******* '***, '*** *** **** ** ** ** ****** '*** ********* ******** ***** *** ****
  1. *** **, **** : ******* ******** ****** ***** *** **** ** **** ******* '*** (***** **, ****), '*** (**** **, ****), '*** (*** *, ****), '*** (*** *, ****), '*** (*** *, ****), '*** (**** **, ****), '***. (*** *, ****)
  2. *** *, **** : ****** ***** * **** ******* ******* **** ******* '*** (***** **, ****), '*** (**** **, ****), '*** (*** *, ****), '*** (*** *, ****), '*** (*** *, ****), '*** (**** **, ****), '***. (*** *, ****)
  3. *** **, **** : ****** ***** ** ******* ********* ******* ******* ** ******* '*** (***** **, ****), '*** (**** **, ****),'***. (*** *, ****) *** '*** (*** *, ****)
  4. *** **, **** : ***** ***** ** ***** ** ****** *** ******* ******* **** '***, '***, '*** ******* *** ********* ** *******
  5. *** **, **** : ******* ***** * ****** ** ****** ** ******* *****
  6. *** **, **** : ******* ***** ****** *** ******** ** *******.
  7. *** **, **** : ** ******* ***** ********* ******* ** ***** ** ********** (******) *** ******* ******* ** ****** '*** *** ********* **** ** ***** ******** ***'* ** ******* ***** ********** ** '*** ******.
  8. *** **, **** : ** ******* ***** ********* ******* ** ***** ** ******* *** ********** (******) ** ******* '*** *** '***.

Download ParaIV Report


Download ParaIV Detailed Report


To get detailed report Contact Us

ParaIV Advanced Search






Please contact contact@researchdelta.com to get more details.